Prospective study with continuous and fixed-Duration Ibrutinib based First Line Treatment in patients with Chronic Lymphocytic Leukemnia in real world setting

Simultan integrierter Boost in der HNO Quality Control Registry

Register und Biobank seltene maligne Tumoren der Schilddrüse und Nebenschilddrüsen

Mammakarzinom des Mannes - Eine prospektive Registerstudie der Universitätsfrauenklinik Magdeburg in Zusammenarbeit mit der GBG (German Breast Group) zur Diagnostik und Therapie des Mammakarzinoms des Mannes

Tumor-Treating-Fields (Optune™) in der Routineanwendung bei der Primärtherapie des Glioblastoms: multizentrische Registerstudie zur Erfassung der Therapieeffektivität und des Rezidivmusters“

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan (PROVIDENCE)

Digital Monitoring with Patient-reported outcomes in cancer care: A randomized controlled trial

Retentionsrate von Acalabrutinib in einem nicht-interventionellen Setting

Clinical Research Platform For Molecular Testing, Treatment, Quality Of Life And Outcome Of Patients With Esophageal, Gastric Or Gastroesophageal Junction Cancer Requiring Palliative Systemic Therapy (SAPHIR)